January 27, 2025
Content View Test
Discover Funded Researchers
Kazuko Nishikura, PhD
ADAR1 Inhibitor: Novel Therapeutic for Melanoma & Immunotherapy Resistance
Korbinian Kropp, MD
Targeting PCBP2 to augment melanoma cell killing by CD4+ T cells
Sarwish Rafiq, PhD, MA
Engaging the endogenous immune system with CAR T cells
Prashanthi Dharanipragada, PhD, MSc
Complex Genomic Rearrangements Driving Sub-Clonal Melanoma Evolution
Devarati Mitra, MD, PhD
Neoadjuvant immunotherapy and radiotherapy for mucosal melanoma
Michael Heiferman, MD
Assessment of Uveal Melanoma Using Machine Learning
Elena Ezhkova, PhD, MS
UV-Induced Epigenetic Changes in the Epidermis in Promoting Melanoma
Weilia Ma, PhD, MS
Effect of Microglia Type I IFN Response in Melanoma Brain Metastasis
Pietro Berico, PhD, MS
A gene regulatory network driving melanoma immune evasion
Kristen Richards, MD
Evaluation of cutaneous immune related adverse events by morphotype
Xiaonan Xu, MD, PhD
Understand metastasis of uveal melanoma in vivo via novel mouse models
Lilit Karapetyan, MD
Deciphering the role of APRIL/TNFSF13 in melanoma-associated TLS formation
Joshua Veatch, MD, PhD
Targeting melanoma with engineered CD4+ T cells
Inaki Etxeberria, PhD
Immunogenic landscape and therapeutic targeting of NRAS public Neoantigens
Poulikos Poulikakos, PhD
Targeting an adaptor function of CDK6 to enhance melanoma immunotherapy
Kari Kendra, MD, PhD
TGFßi NK Cell Infusions in Patients with Melanoma Brain Metastases
Pere Puigserver, PhD
NKT infiltration and rejection in melanomas
Emily Bernstein, PhD
Chromatin Remodeling Alterations and Consequences for Melanoma Metastasis
Hilary Coller, PhD
Noncanonical Autophagy Inhibition as a New Approach to Melanoma Therapy
Brent Hanks, MD, PhD
Role of the Gli2 Pathway in Melanoma Immunotherapy Resistance
David Soto-Pantoja, PhD
Biomarkers to Predict Melanoma Patient Immunotherapy Outcomes
Praveen Agrawal, PhD
Role of Core Fucosylation in the Resistance to Immunotherapy of Melanoma
Stanley (Ching-Cheng) Huang, PhD
Exploiting Metabolic Vulnerabilities of Macrophages for Melanoma Treatment
Nicolas Vabret, PhD